You are here:

nebivolol tablets 5mg (Nebilet)


Following a re-submission.

nebivolol (Nebilet®) is accepted for use within NHS Scotland for the treatment of stable mild and moderate chronic heart failure (CHF) in addition to standard therapies in elderly patients ≥70 years.

Compared to placebo, nebivolol, added to standard therapy, was associated with improved left ventricular function and a reduction in a composite endpoint combining all cause mortality and cardiovascular hospitalisation rates in elderly patients with chronic heart failure. There are no direct comparisons with other beta-blockers that are available at a lower acquisition cost.

Drug Details

Drug Name: nebivolol tablets 5mg (Nebilet)
SMC Drug ID: 214/05
Manufacturer: A Menarini Pharmaceuticals UK Ltd
Indication: chronic heart failure
BNF Category:
Submission Type: Resubmission
Status: Accepted
Date Advice Published: 13 August 2007

Archived Advice

Full submission 11 September 2006